Three-Part Pricing to Reward Pharmaceutical Innovation and Increase Access: Case of PCSK9 Inhibitors

Saved in:
Bibliographic Details
Published in:Value in health 2018-05, Vol.21, p.S65
Main Authors: Cheng, W, Hlavka, JP, Snowberg, E, Van Nuys, K, Goldman, DP
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:1098-3015
DOI:10.1016/j.jval.2018.04.387